AFJK Aimei Health Technology Co., Ltd
USFinancial ServicesAs of 2026-07-10 16:00
Why AFJK matters now
Aimei Health Technology Co., Ltd (AFJK) is a US stock in Financial Services. The latest InvestLog snapshot shows $12.69 with -1.55% on the session and $77.7M in market capitalization; recent performance reads 1-month -18.22% and YTD -46.85%.
The latest financial table shown here is Q4 2025, with revenue of $0.00, net income of $98.1K, and EPS of $0.02. Investors can compare that operating picture with valuation signals such as P/E 243.87 and FCF yield -0.2%.
The latest indexable market news headline is "AIMEI HEALTH TECHNOLOGY CO., LTD. ANNOUNCES TERMINATION OF BUSINESS COMBINATION AGREEMENT WITH UNITED HYDROGEN GROUP INC." from GlobeNewsWire.
Valuation
P/E (TTM)
243.87
PEG
—
P/B
4.38
P/S
0.00
EV/EBITDA
-434.28
DCF Value
$-0.50
FCF Yield
-0.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
3.7%
ROA
7.5%
ROIC
-4.5%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $0.00 | $98.1K | $0.02 |
| FY 2025 | $0.00 | $1.1M | $0.17 |
| Q3 2025 | $0.00 | $352.0K | $0.06 |
| Q2 2025 | $0.00 | $425.0K | $0.07 |
Related Stocks
Latest News
Company Info
Sector
Financial Services
Industry
Shell Companies
Country
US
Exchange
—
Beta
0.23
Aimei Health Technology Co., Ltd. currently lacks substantial business operations. Its core purpose is to pursue a strategic business combination, which may take the form of a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or a similar transaction with one or more companies. The firm intends to acquire businesses operating in the biopharmaceutical, medical technology/device, diagnostic, and other service-related industries. Aimei Health Technology Co., Ltd. was established in 2023 and is based in New York, New York.